爱博医疗收盘下跌1.82%，滚动市盈率38.74倍，总市值146.44亿元

Company Overview - Aibo Medical closed at 75.72 yuan on August 1, with a decline of 1.82%, resulting in a rolling PE ratio of 38.74 times and a total market capitalization of 14.644 billion yuan [1] - The company ranks 80th in the medical device industry, which has an average PE ratio of 53.65 times and a median of 37.22 times [1] Shareholder Information - As of March 31, 2025, Aibo Medical had 9,729 shareholders, a decrease of 94 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Business Operations - Aibo Medical focuses on the independent research, production, sales, and related services of ophthalmic medical devices, with key products including artificial lenses, surgical products, orthokeratology lenses, myopia control products, contact lenses, and other vision care products [1] Financial Performance - In the latest quarterly report for Q1 2025, Aibo Medical reported revenue of 357 million yuan, a year-on-year increase of 15.07%, while net profit was 92.5581 million yuan, reflecting a year-on-year decrease of 10.05%, with a gross profit margin of 64.60% [1]